The latter is of specific interest in the context of HIV-1 vaccine development due to the resistance of HLA-E to downregulation by the HIV-1 Nef during infection [46], as well as displaying a low level of allelic variation, with only forty three existing variants as opposed to the thousands of classical HLA class I molecules [47]. Here, S100B is linked to infection.